The table below provides, for the periods indicated, information pertaining to the calculation of earnings per share, common stock equivalents, weighted-average number of antidilutive options and restricted stock units, and shares issued (amounts in thousands):


	Three months ended April 30,				Six months ended April 30,
	2026		2025		2026		2025
Numerator:
Net income as reported	$	260,591	$	352,447	$	471,523	$	530,150

Denominator:
Basic weighted-average shares	95,144		99,890		95,422		100,360
Common stock equivalents (1)	611		695		708		848
Diluted weighted-average shares	95,755		100,585		96,130		101,208

Other information:

Weighted-average number of antidilutive options and restricted stock units (2)	12		123		75		126
Shares issued under stock incentive and employee stock purchase plans	94		11		408		379

(1) Common stock equivalents represent the dilutive effect of outstanding in-the-money stock options using the treasury stock method and shares expected to be issued upon the conversion of restricted stock units under our equity award programs.

(2) Weighted-average number of antidilutive options and restricted stock units are based upon the average closing price of our common stock on the New York Stock Exchange for the period.